Coulie, Pierre G.

Integrating next-generation dendritic cell vaccines into the current cancer immunotherapy landscape

Garg, A. D., Coulie, P. G., Van den Eynde, B. J., & Agostinis, P. (2017) · Trends in Immunology

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 340

Membrane protein GARP is a receptor for latent TGF‐β on the surface of activated human Treg

Stockis, J., Colau, D., Coulie, P. G., & Lucas, S. (2009) · European Journal of Immunology

T-cell and B-cell ImmunologyTGF-β signaling in diseases

Cited by 252

Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo

Cuende, J., Liénart, S., Dedobbeleer, O., van der Woning, B., De Boeck, G., Stockis, J., Huygens, C., Colau, D., Somja, J., Delvenne, P., et al. (2015) · Science Translational Medicine

T-cell and B-cell ImmunologyTGF-β signaling in diseases

Cited by 155

Synergistic activation of human t cells by interleukin 1 and interleukin 6

Houssiau, F. A., Coulie, P. G., Olive, D., & Snick, J. V. (1988) · European Journal of Immunology

T-cell and B-cell ImmunologyCytokine Signaling Pathways and Interactions

Cited by 152

Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8

Stockis, J., Liénart, S., Colau, D., Collignon, A., Nishimura, S. L., Sheppard, D., Coulie, P. G., & Lucas, S. (2017) · Proceedings of the National Academy of Sciences

T-cell and B-cell ImmunologyTGF-β signaling in diseases

Cited by 111